Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons:: Relevance to schizophrenia

被引:79
作者
Cabungcal, Jan-Harry [1 ]
Nicolas, Dominique
Kraftsik, Rudolf
Cuenod, Michel
Do, Kim Q.
Hornung, Jean-Pierre
机构
[1] Univ Lausanne, Ctr Res Psychiat Neurosci, Dept Adult Psychiat, CH-1008 Prilly, Switzerland
[2] Univ Lausanne, Fac Biol & Med, Dept Biol Cellulaire & Morphol, Lausanne, Switzerland
关键词
animal model; anterior cingulate cortex; gamma-amino butyric acid; glutathione; GBR; 12909; inhibitory interneurons; L-buthionine-(S; R)-sulfoximine; (BSO); oxidative stress; parvalbumin-immunoreactive; schizophrenia;
D O I
10.1016/j.nbd.2006.01.003
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
A series of studies in schizophrenic patients report a decrease of glutathione (GSH) in prefrontal cortex (PFC) and cerebrospinal fluid, a decrease in mRNA levels for two GSH synthesizing enzymes and a deficit in parvalbumin (PV) expression in a subclass of GABA neurons in PFC. GSH is an important redox regulator, and its deficit could be responsible for cortical anomalies, particularly in regions rich in dopamine innervation. We tested in an animal model if redox imbalance (GSH deficit and excess extracellular dopamine) during postnatal development would affect PV-expressing neurons. Three populations of interneurons immunolabeled for calcium-binding proteins were analyzed quantitatively in 16-day-old rat brain sections. Treated rats showed specific reduction in parvalbumin immunoreactivity in the anterior cingulate cortex, but not for calbindin and calretinin. These results provide experimental evidence for the critical role of redox regulation in cortical development and validate this animal model used in schizophrenia research. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:624 / 637
页数:14
相关论文
共 113 条
[11]
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[12]
Cabungcal JH, 2004, SCHIZOPHR RES, V67, P118
[13]
CABUNGCAL JH, ABSTR SOC NEUROSCI, V797, P13
[14]
Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex [J].
Carder, RK ;
Leclerc, SS ;
Hendry, SHC .
CEREBRAL CORTEX, 1996, 6 (02) :271-287
[15]
Interactions between monoamines, glutamate, and GABA in schizophrenia: New evidence [J].
Carlsson, A ;
Waters, N ;
Holm-Waters, S ;
Tedroff, J ;
Nilsson, M ;
Carlsson, ML .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :237-260
[16]
Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system [J].
Castagne, V ;
Gautschi, M ;
Lefevre, K ;
Posada, A ;
Clarke, PGH .
PROGRESS IN NEUROBIOLOGY, 1999, 59 (04) :397-423
[17]
An animal model with relevance to schizophrenia:: Sex-dependent cognitive deficits in osteogenic disorder-Shionogi rats induced by glutathione synthesis and dopamine uptake inhibition during development [J].
Castagné, V ;
Cuénod, M ;
Do, KQ .
NEUROSCIENCE, 2004, 123 (04) :821-834
[18]
Cauli B, 1997, J NEUROSCI, V17, P3894
[19]
PARVALBUMIN IMMUNOREACTIVITY - A RELIABLE MARKER FOR THE EFFECTS OF MONOCULAR DEPRIVATION IN THE RAT VISUAL-CORTEX [J].
CELLERINO, A ;
SICILIANO, R ;
DOMENICI, L ;
MAFFEI, L .
NEUROSCIENCE, 1992, 51 (04) :749-753
[20]
Determination of the L-ascorbic acid requirements in Wister osteogenic disorder Shionogi rats for prolonged carcinogenesis experiments [J].
Chan, SWY ;
Reade, PC .
LABORATORY ANIMALS, 1996, 30 (04) :337-346